IMR Press / FBL / Volume 18 / Issue 4 / DOI: 10.2741/4172

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.


Endothelial progenitor cells and atherosclerosis

Show Less
1 Department of Cardiology, the 8th Renmin hospital, Shanghai, No.8 Cao Bao Road,Shanghai, 200235, China
Front. Biosci. (Landmark Ed) 2013, 18(4), 1194–1201;
Published: 1 June 2013

Atherosclerosis is due to inflammation and endothelial dysfunction and damage caused by a variety of factors. Dysfunction of endothelial progenitor cells (EPCs) that differentiate into mature endothelial cell contributes to the development of atherosclerosis. Both the number and functionality of EPCs are regulated, particularly in vascular repair. Further elucidation of the role of EPCs in atherosclerosis could potentially enable the development of novel strategies for prevention and treatment of pathological changes in atherosclerosis.

Endothelial progenitor cells
Back to top